Neurologic consequences of HTLV-II infection in injection-drug users

Neurology

Volumn 46, Issue 6, 1996, Pages 1556-1560

  Dooneief, G ^a,b,c   Marlink, R ^d   Bell, K ^a,b,c   Marder, K ^a,b,c   Renjifo, B ^d   Stern, Y ^a,b,c   Mayeux, R ^a,b,c  

^a Vagelos College of Physicians and Surgeons   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c Box 16 ^*  (United States)

^d Harvard AIDS Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLADDER DYSFUNCTION; COGNITIVE DEFECT; CONTROLLED STUDY; DISABILITY; DRUG ABUSE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 2; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROPATHY; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0029902565     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.6.1556     Document Type: Article

References (11)

1. Hjelle B. Human T-cell leukemia/lymphoma viruses: life cycle, pathogenicity, epidemiology and diagnosis. Arch Pathol Lab Med 1991;115:440-450.
2. Hjelle B, Appenzeller O, Mills R, et al. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645-646.
3. Lee H, Swanson P, Rosenblatt J, et al. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet 1991;337:1435-1439.
4. Centers for Disease Control. CDC classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR 1986;35:334-339.
5. Marder K, Stern Y, Malouf R, et al. Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without acquired immunodeficiency syndrome: relationship to head injury. Arch Neurol 1992;49:1169-1175.
6. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1144-1152.
7. Marder K, Liu X, Stern Y, et al. Neurological signs and symptoms in a cohort of gay men followed for 4.5 years. Neurology 1995;45:261-266.
8. Chen Y-M, Lee T-H, Wiktor S, et al. Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection. Lancet 1990;336:1153-1155.
9. Okayama A, Korber B, Chen Y-M, et al. Unusual pattern of antibodies to human T-cell leukemia virus type-1 in family members of adult T-cell leukemia patients. Blood 1991;78:3323-3329.
10. Jacobson S, Lehkey T, Nishimura M, Robinson S, McFarlin D, Dhib-Jalbut S. Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol 1993;33:392-396.
11. Hollsberg P, Hafler D. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 1993;328:1173-1182.